ConductScience.org, home

Paper29449366

Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.

Hanson JLS and 6 others. Circ Heart Fail, 2018. Cited by 91 papers, by iCite.

Cite this record

ConductScience Library. Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin. Papers, record 29449366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29449366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.
PubMed
Journal
Circ Heart Fail
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
4.26
iCite
Revised in PubMed
2019-05-07
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hanson JLSJacquelyn L S
2Arvanitis MMarios
3Koch CMClarissa M
4Berk JLJohn L
5Ruberg FLFrederick L
6Prokaeva TTatiana
7Connors LHLawreen H

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
PrealbuminMajor topic
Predictive Value of TestsMajor topic
ROC CurveMajor topic
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Prognosis
Proportional Hazards Models
Retrospective Studies
Ventricular Function, Left

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AG031804NIA NIH HHSUnited StatesR01AG031804PubMed and NIHNIH RePORTER
R56 AG031804NIA NIH HHSUnited StatesR01AG031804PubMed and NIHNIH RePORTER
R56AG031804NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in29449369Serum Transthyretin: Predictor of Amyloidosis Outcomes?https://conductscience.org/library/papers/29449369

Source PubMed

Download CSV of comments and corrections

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114330531METABOLISM OF IODINE-131--LABELED THYROXINE-BINDING PREALBUMIN IN MAN.Science1965https://conductscience.org/library/papers/14330531PubMed
217378745Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition.Clin Chem Lab Med2007https://conductscience.org/library/papers/17378745PubMed
34038581Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at risk relatives.Am J Med Sci1985https://conductscience.org/library/papers/4038581PubMed
414746554The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.J Intern Med2004https://conductscience.org/library/papers/14746554PubMed
522620969Senile systemic amyloidosis: are regional differences real or do they reflect different diagnostic suspicion and use of techniques?Amyloid2012https://conductscience.org/library/papers/22620969PubMed
66090552Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy.J Lab Clin Med1984https://conductscience.org/library/papers/6090552PubMed
73818577Analyses of prealbumin mRNAs in individuals with familial amyloidotic polyneuropathy.J Biochem1986https://conductscience.org/library/papers/3818577PubMed
824563469Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.Circulation2014https://conductscience.org/library/papers/24563469PubMed
925758359Cardiac amyloidosis: the great pretender.Heart Fail Rev2015https://conductscience.org/library/papers/25758359PubMed
1022329529Transthyretin cardiac amyloidoses in older North Americans.J Am Geriatr Soc2012https://conductscience.org/library/papers/22329529PubMed
1126610878Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.J Am Coll Cardiol2015https://conductscience.org/library/papers/26610878PubMed
1223193944THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.Curr Med Res Opin2013https://conductscience.org/library/papers/23193944PubMed
1315983293Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.Arch Intern Med2005https://conductscience.org/library/papers/15983293PubMed
1419065297Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity.Amyloid2008https://conductscience.org/library/papers/19065297PubMed
1522645360Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22645360PubMed
1624368466Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.JAMA2013https://conductscience.org/library/papers/24368466PubMed
1726660283Wild-Type Transthyretin Amyloid Cardiomyopathy: A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications.Circulation2016https://conductscience.org/library/papers/26660283PubMed
1819752327Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.Circulation2009https://conductscience.org/library/papers/19752327PubMed
1923608605Senile systemic amyloidosis: clinical features at presentation and outcome.J Am Heart Assoc2013https://conductscience.org/library/papers/23608605PubMed
2016928339Cardiac amyloidosis: shifting our impressions to hopeful.Curr Heart Fail Rep2006https://conductscience.org/library/papers/16928339PubMed

See all 30 referencesDownload CSV of references

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
42769982The Arrhythmic Burden of Cardiac Amyloidosis: A Comprehensive Review.Heart Views2026https://conductscience.org/library/papers/42769982PubMed
42658464Impact of Tafamidis on Transthyretin Concentration and Its Relation to All-Cause Mortality in Patients with Transthyretin Amyloid Cardiomyopathy: An Analysis from ATTR-ACT.Cardiol Ther2026https://conductscience.org/library/papers/42658464PubMed
42622768ACO-SWITCH: Rationale and Design of a Phase 4 Study Evaluating Serum Transthyretin in ATTR-CM After Switching from Tafamidis to Acoramidis.Cardiol Ther2026https://conductscience.org/library/papers/42622768PubMed
42576135Transthyretin Amyloid Cardiomyopathy in Women: Epidemiology, Diagnostic Delay, and Clinical Implications.Cardiol Ther2026https://conductscience.org/library/papers/42576135PubMed
42326538Development of Human iPSC-based Microphysiogical Models of Transthyretin Amyloid Cardiomyopathy.Res Sq2026https://conductscience.org/library/papers/42326538PubMed
42307157Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis.JACC CardioOncol2026https://conductscience.org/library/papers/42307157PubMed
42305910Unveiling the unseen: navigating heart involvement in amyloidosis with biomarkers beyond the horizons of imaging.Eur Heart J Imaging Methods Pract2026https://conductscience.org/library/papers/42305910PubMed
42257495Evaluation of the Current ATTR-CM Treatment Landscape via a Mathematical Model of TTR Dissociation and Amyloid Formation.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42257495PubMed
42228252Context-of-use-Guided Development and Validation of a Transthyretin Immunoassay: A Framework for Biomarker Assay Design.AAPS J2026https://conductscience.org/library/papers/42228252PubMed
42201475Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis.Clin Pharmacokinet2026https://conductscience.org/library/papers/42201475PubMed
42132180Pathogenic Characterization of a Novel G47R Transthyretin Mutation in Early-Onset Amyloid Cardiomyopathy.J Am Heart Assoc2026https://conductscience.org/library/papers/42132180PubMed
41776317Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations.NPJ Cardiovasc Health2025https://conductscience.org/library/papers/41776317PubMed
41734414Association Between Occupational Physical Work Exposure and Wild-Type Transthyretin Cardiomyopathy.JACC Adv2026https://conductscience.org/library/papers/41734414PubMed
41513988Phenomenological model of transthyretin stabilization.Sci Rep2026https://conductscience.org/library/papers/41513988PubMed
41088066Circulating transthyretin with atrial morpho-functional phenotypes and atrial fibrillation risk, and the modifying role of BMI.BMC Med2025https://conductscience.org/library/papers/41088066PubMed
40889301In vitro and in vivo disease models of cardiac amyloidosis: progress, pitfalls, and potential.Cardiovasc Res2025https://conductscience.org/library/papers/40889301PubMed
40852192Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis.Eur Heart J Open2025https://conductscience.org/library/papers/40852192PubMed
40717228Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis.Ann Med2025https://conductscience.org/library/papers/40717228PubMed
40684004Current and Future Treatment Landscape of Transthyretin Amyloid Cardiomyopathy.Cardiol Ther2025https://conductscience.org/library/papers/40684004PubMed
40067885Initiation of transthyretin aggregation at neutral pH by fluid agitation.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40067885PubMed

See all 59 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29449366

GET https://conductscience.org/api/papers/v1/29449366/references?page=2